Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: Evidence for a role in progression of astrocytic tumors (Review)

International Journal of Molecular Medicine

Volumn 3, Issue 5, 1999, Pages 531-536

  Moriyama, Takuzou ^a   Kataoka, Hiroaki ^a   Koono, Masashi ^a   Wakisaka, Shinichiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Brain tumor; C Met; Glioblastoma; Hepatocyte growth factor; Scatter factor

Indexed keywords

SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

BIOLOGICAL MODEL; BRAIN TUMOR; CANCER INVASION; GENE EXPRESSION; GENETICS; GLIOBLASTOMA; HUMAN; METABOLISM; NERVOUS SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

BRAIN NEOPLASMS; GENE EXPRESSION; GLIOBLASTOMA; HEPATOCYTE GROWTH FACTOR; HUMANS; MODELS, NEUROLOGICAL; NEOPLASM INVASIVENESS; NERVOUS SYSTEM; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION;

EID: 0033124857     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.5.531     Document Type: Article

References (66)

1. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S and Daikuhara Y: Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81: 414-419, 1988.
2. Nakamura T, Nawa K, Ichihara A, Kaise N and Nishino T: Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 224: 311-316, 1987.
3. Stoker M, Gherardi E, Ferryman M and Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239-242, 1987.
4. Gherardi E, Gray J, Stoker M, Ferryman M and Furlong R: Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci USA 86: 5844-5848, 1989.
5. Weidner KM, Arakaki N, Hartmann G, Vandekerckhove J, Weingart S, Rieder H, Fonatsch C, Tsubouchi H, Hishida T, Daikuhara Y and Birchmeier W: Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88: 7001-7005, 1991.
6. Zarnegar R and Michalopoulos GK: The many faces of hepatocyte growth factor from hepatopoiesis to hematopoiesis. J Cell Biol 129: 1177-1180, 1989.
7. Boros P and Miller CM: Hepatocyte growth factor: a multifunctional cytokine. Lancet 345: 293-295, 1995.
8. Matsumoto K and Nakamura T: Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119: 591-600, 1996.
9. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF and Aaronson SA: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804, 1991.
10. Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, Narsimhan RP, Hartmann G, Zarnegar R, Michalopoulos GK, Birchmeier W and Comoglio PM: Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 10: 2867-2878, 1991.
11. Cooper CS, Park M, Blair DC, Tainsky MA, Huebner K, Croce CM and Vande Woude GF: Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311: 29-33, 1984.
12. Rubin JS, Bottaro DP and Aaronson SA: Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta 1155: 357-371, 1993.
13. Naka D, Ishii T, Yoshiyama Y, Miyazawa K, Hara H, Hishida T and Kitamura N: Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J Biol Chem 267: 20114-20119, 1992.
14. Shimomura T, Ochiai M, Kondo J and Morimoto Y: A novel protease obtained from FBS-containing culture supernatant, that processes single chain form hepatocyte growth factor to two chain form in serum-free culture. Cytotechnology 8: 219-229, 1992.
15. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y and Kitamura N: Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem 268: 10024-10028, 1993.
16. Shimomura T, Kondo J, Ochiai M, Naka D, Miyazawa K, Morimoto V and Kitamura N: Activation of the zymogen of hepatocyte growth factor activator by thrombin. J Biol Chem 268: 22927-22932, 1993.
17. Miyazawa K, Shimomura T, Naka D and Kitamura N: Proteolytic activation of hepatocyte growth factor in response to tissue injury. J Biol Chem 269: 8966-8970, 1994.
18. Yamada T, Tsubouchi H, Daikuhara Y, Prat M, Comoglio PM, McGeer PL and McGeer EG: Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues. Brain Res 637: 308-312, 1994.
19. Yamada T, Yoshiyama Y, Tsuboi Y and Shimomura T: Astroglial expression of hepatocyte growth factor and hepatocyte growth factor activator in human brain tissues. Brain Res 762: 251-255, 1997.
20. Fenton H, Finch PW, Rubin JS, Rosenberg JM, Taylor WG, Kuo Leblanc V, Rodriguez Wolf M, Baird A, Schipper HM and Stopa EG: Hepatocyte growth factor (HGF/SF) in Alzheimer's disease. Brain Res 779: 262-270, 1998.
21. Yamagata T, Muroya K, Mukasa T, Igarashi H, Momoi M, Tsukahara T, Arahata K, Kumagai H and Momoi T: Hepatocyte growth factor specifically expressed in microglia activated Ras in the neurons, similar to the action of neurotrophic factors. Biochem Biophys Res Commun 210: 231-237, 1995.
22. Hamanoue M, Takemoto N, Matsumoto K, Nakamura T, Nakajima K and Kohsaka S: Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J Neurosci Res 43: 554-564, 1996.
23. Di Renzo MF, Bertolotto A, Olivero M, Putzolu P, Crepaldi T, Schiffer D, Pagni CA and Comoglio PM: Selective expression of the Met/HGF receptor in human central nervous, system microglia. Oncogene 8: 219-222, 1993.
24. Nabeshima K, Shimao Y, Sato S, Kataoka H, Moriyama T, Kawano H, Wakisaka S and Koono M: Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study. Histopathology 31: 436-443, 1997.
25. Jung W, Castren E, Odenthal M, Vande Woude GF, Ishii T, Dienes H-P, Lindholm D and Schirmacher P: Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell Biol 126: 485-494, 1994.
26. Honda S, Kagoshima M, Wanaka A, Tohyama M, Matsumoto K and Nakamura T: Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor. Brain Res Mol Brain Res 32: 197-210, 1995.
27. Achim CL, Katyal S, Wiley CA, Shiratori M, Wang G, Oshika E, Petersen BE, Li J-M and Michalopoulos GK: Expression of HGF and c-Met in the developing and adult brain. Dev Brain Res 102: 299-303, 1997.
28. Miyazawa T, Matsumoto K, Ohmichi H, Katoh H, Yamashima T and Nakamura T: Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor. J Cereb Blood Flow Metab 18: 345-348, 1998.
29. Bronner-Fräser M: Hepatocyte growth factor/scatter factor (HGF/SF) in early development: evidence for a role in neural induction. Trends Genet 11: 423-425, 1995.
30. Streit A, Stern CD, Thery C, Ireland GW, Aparicio S, Sharpe MJ and Gherardi E: A role for HGF/SF in neural induction and its expression in Hensen's node during gastrulation. Development 121: 813-824, 1995.
31. Krasnoselsky A, Massay MJ, Defrances MC, Michalopoulos G, Zarnegar R and Ratner N: Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas. J Neurosci 14: 7284-7290, 1994.
32. Moriyama T, Kataoka H, Tsubouchi H and Koono M: Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro. FEBS Lett 372: 78-82, 1995.
33. Moriyama T, Kataoka H, Seguchi K, Tsubouchi H and Koono M: Effects of hepatocyte growth factor (HGF) on human glioma cells in vitro: HGF acts as a motility factor in glioma cells. Int J Cancer 66: 678-685, 1996.
34. Rosen EM, Laterra J, Joseph A, Jin L, Fuchs A, Way D, Witte M, Weinand M and Goldberg ID: Scatter factor expression and regulation in human glial tumors. Int J Cancer 67: 248-255, 1996.
35. Shiota G, Kawasaki H and Nakamura T: Coexpression of hepatocyte growth factor and its receptor (c-met oncogene) in HGL4 glioblastoma cells. Oncology 53: 511-516, 1996.
36. Koochekpour S, Jeffers M, Rulong S, Taylor G, Klineberg E, Hudson EA, Resau JH and Vande Woude GF: Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res 57: 5391-5398, 1997.
37. Yamamoto S, Wakimoto H, Aoyagi M, Hirakawa K and Hamada H: Modulation of motility and proliferation of glioma cells by hepatocyte growth factor. Jpn J Cancer Res 88: 564-577, 1997.
38. Moriyama T, Kataoka H, Kawano H, Yokogami K, Nakano S, Goya T, Uchino H, Koono M and Wakisaka S: Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. Cancer Lett 124: 149-155, 1998.
39. Hirose Y, Kojima M, Sagoh M, Murakami H, Yoshida K, Shimazaki K and Kawase T: Immunohistochemical examination of c-Met protein expression in astrocytic tumors. Acta Neuropathol 95: 345-351, 1998.
40. Lamszus K, Schmidt NO, Jin L, Laterra J, Zagzag D, Way D, Witte M, Weinand M, Goldberg ID, Westphal M and Rosen EM: Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer 75: 19-28, 1998.
41. Landau BJ, Kwaan HC, Verrusio EN and Brem SS: Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in human brain tumors. Cancer Res 54: 1105-1108, 1994.
42. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F and Comoglio PM: Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 11: 4825-4833, 1992.
43. Shimomura T, Miyazawa K, Komiyama Y, Hiraoka H, Naka D, Morimoto Y and Kitamura N: Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 229: 257-261, 1995.
44. Mizuno K, Takehara T and Nakamura T: Proteolytic activation of a single-chain precursor of hepatocyte growth factor by extracellular serine-protease. Biochem Biophys Res Commun 189: 1631-1638, 1992.
45. Naldini L, Vigna E, Bardelli A, Follenzi A, Galimi F and Comoglio PM: Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by stoichiometric reaction. J Biol Chem 270: 603-611, 1995.
46. Kataoka H, Uchino H, Asada Y, Hatakeyama K, Nabeshima K, Sumiyoshi A and Koono M: Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver. Int J Cancer 72: 878-884, 1997.
47. Hamada K, Kuratsu J, Saitoh Y, Takeshima H, Nishi T and Ushio Y: Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 77: 1877-1883, 1996.
48. Smirnova IV, Ho GJ, Fenton JW II and Festoff BW: Extravascular proteolysis and the nervous system: serine protease/serpin balance. Semin Thromb Hemost 20: 426-432, 1994.
49. Merzak A and Pilkington GJ: Molecular and cellular pathology of intrinsic brain tumours. Cancer Metastasis Rev 16: 155-177, 1997.
50. Lund-Johansen M, Bjerkvig RB, Humphrey PA, Bigner SH, Bigner DD and Laerum O-D: Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res 50: 6039-6044, 1990.
51. Engerbaaten O, Bjerkvig R, Pedersen P-H and Laerum OD: Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro. Int J Cancer 53: 209-214, 1993.
52. El-Obeid A, Bongeam-Rudloff E, Sorby M, Ostman A, Nister M and Westermark B: Cell scattering and migration induced by autocrine transforming growth factor human glioma cells in vitro. Cancer Res 57: 5598-5604, 1997.
53. Ohnishi T, Arita N, Hayakawa T, Kawahara K, Kato K and Kakinuma A: Purification of motility factor (GMF) from human malignant glioma cells and its biological significance in tumor invasion. Biochem Biophys Res Commun 193: 518-525, 1993.
54. Dunsmore SE, Rubin JS, Kovacs SO, Chedid M, Parks WC and Welgus HG: Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J Biol Chem 271: 24576-24582, 1996.
55. Li H, Shimura H, Aoki Y, Date K, Matsumoto K, Nakamura T and Tanaka M: Hepatocyte growth factor stimulates the invasion of gallbladder carcinoma cell lines in vitro. Clin Exp Metastasis 16: 74-82, 1998.
56. Paciucci R, Vila MR, Adell T, Diaz VM, Tora M, Nakamura T and Real FX: Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met. Am J Pathol 153: 201-212, 1998.
57. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y and Nakamura T: Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res 57: 3305-3313, 1997.
58. Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID and Johnston P: Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab Invest 76: 565-577, 19977
59. Deryugina EI, Bourdon MA, Luo GX, Reisfeld RA and Strongin A: Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci 110: 2473-2482, 1997.
60. Belin ATJ, Paganetti PA and Schwab ME: Membrane-type I matrix metalloproteinase (MTI-MMP) enables invasive migration of glioma cells in central nervous system white matter. J Cell Biol 144: 373-384, 1999.
61. Laterra J, Rosen E, Naw M, Rauganathan S, Fielding K and Johnston P: Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. Biochem Biophys Res Commun 235: 743-747, 1997.
62. Bussolina F, DiRenzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A and Comoglio PM: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641, 1992.
63. Shweiki D, Itin A, Soffer D and Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
64. Plate KH, Breier G, Weich HA and Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.
65. Moriyama T, Kataoka H, Hamasuna R, Yokogaini K, Uehara H, Kawano H, Goya T, Tsubouchi H, Koono M and Wakisaka S: Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem Biophys Res Commun 249: 73-77, 1998.
66. Uma NM, Rao UNM, Sonmez-Alpan E and Michalopoulos GK: Hepatocyte growth factor and c-MET in benign and malignant peripheral nerve sheath tumors. Hum Pathol 28: 1066-1070, 1997.